The Effect Of CPAP On Erectile And Endothelial Dysfunction In Impotent Men With Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$609,559.00
Summary
Erectile dysfunction is common in men with obstructive sleep apnea, due to vascular damage, which leads to heart attack. CPAP is the preferred treatment for patients with OSA because of its well-proven ability to decrease sleepiness and improve blood pressure control. This study will establish if CPAP can also improve erectile and vascular endothelial dysfunction. These results will shed light on the mechanisms that underpin the relationship between OSA and Erectile Dysfunction.
Chronotherapy Of Hypertension In Obstructive Sleep Apnoea
Funder
National Health and Medical Research Council
Funding Amount
$232,738.00
Summary
Obstructive Sleep Apnoea (OSA) is linked with excess cardiovascular disease, and this is partly attributed to increased high blood pressure (hypertension). Understanding how both conditions exacerbate hypertension and whether blood pressure control can be improved by altering the time that medication is taken will lead to improvements in health.
Cardiometabolic Changes After Continuous Positive Airway Pressure Treatment For Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$82,421.00
Summary
CPAP is the preferred treatment for patients with OSA because of its well-proven ability to decrease sleepiness and improve blood pressure control. This study will definitively establish if CPAP can also improve markers of cardio-metabolic health, such as visceral fat, insulin sensitivity, central blood pressure and arterial stiffness. The results of the study will shed light on the broader health consequences of OSA and contributes to the development of more targeted treatment strategies.
Metabolic And Neurobiological Changes After Continuous Positive Airway Pressure Treatment For Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$503,497.00
Summary
CPAP is the preferred treatment for patients with OSA because of its well-proven ability to decrease sleepiness and improve blood pressure control. This study will definitively establish if CPAP can also improve markers of cardio-metabolic health, such as visceral fat, insulin sensitivity, central blood pressure and arterial stiffness. The results of the study will shed light on the broader health consequences of OSA and contribute to the development of more targeted treatment strategies.
The Interaction Between Obstructive Sleep Apnea And Cardiovascular Risk Factors On Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$1,263,050.00
Summary
Cardiovascular (CV) disease and obstructive sleep apnoea (OSA) are common causes of morbidity and mortality. OSA is an independent risk factor for CV disease but little is known about which patients with OSA are likely to develop CV disease, and the interaction between OSA and other CV risk factors. We seek to better understand this interaction by exploring which of 4,100 well characterised patients in the West Australian Sleep Health Study (WASHS) 2005-2010 have developed CV disease.
The Sleep Apnea Cardio Vascular Endpoints (SAVE) Study
Funder
National Health and Medical Research Council
Funding Amount
$1,177,047.00
Summary
Obstructive sleep apnea (OSA) affects 7% of the population and is increasing with the global epidemic of obesity. Research suggests that OSA may be a cause of premature cardiovascular (CV) disease, but definitive proof is lacking. This 5-year trial will answer this question by comparing the rate of CV events (eg stroke, heart attack) in OSA patients who are treated, versus those not treated, with CPAP. The results may lead to a new medical approach to the prevention of CV disease.
Obstructive sleep apnea (OSA) affects 7% of the population and is increasing with the global epidemic of obesity. Research suggests that OSA may be a cause of premature cardiovascular (CV) disease, but definitive proof is lacking. This 5-year trial will answer this question by comparing the rate of CV events (eg stroke, heart attack) in OSA patients who are treated, versus those not treated, with CPAP. The results may lead to a new medical approach to the prevention of CV disease.
The Impact Of CPAP Treatment On Carotid Artery Atherosclerosis In Heavy Snoring And Mild Sleep Disordered Breathing
Funder
National Health and Medical Research Council
Funding Amount
$697,512.00
Summary
Mild sleep disordered breathing, including habitual snoring, is a very common problem in the adult population, with a prevalence of between 20-40%. Increasingly it is now recognised that habitual snoring may be an independent risk factor for the development of stroke. In this proposal we will explore the hypothesis that treatment for snoring will slow or stop the development of carotid artery atherosclerosis.
A Randomised Controlled Trial Of A Simplified Management Strategy Versus Standard Care In Moderate To Severe OSA
Funder
National Health and Medical Research Council
Funding Amount
$561,400.00
Summary
Currently breathing difficulties during sleep known as obstructive sleep apnea (OSA) are undertreated in our community. This reflects an inability of the current diagnostic and treatment strategies to deal with the high clinical burden of OSA. As a result, in particular in rural and remote areas, many have long waits for treatment, or no access to therapy at all. The purpose of this project is to evaluate a simplified protocol for the management of OSA. This will be done using diagnostic devices ....Currently breathing difficulties during sleep known as obstructive sleep apnea (OSA) are undertreated in our community. This reflects an inability of the current diagnostic and treatment strategies to deal with the high clinical burden of OSA. As a result, in particular in rural and remote areas, many have long waits for treatment, or no access to therapy at all. The purpose of this project is to evaluate a simplified protocol for the management of OSA. This will be done using diagnostic devices and treatment strategies that are more widely available than the current approaches to the diagnosis and management of obstructive sleep apnea. This will involve measurement of the numbers of falls in oxygen levels in a patient via a device to measure oxygen levels called an oximeter. These falls in oxygen levels correlate well with breath holding episodes during sleep characteristic of OSA. Treatment can be commenced in the patient's home depending on these results. We intend to compare these new approaches with the current best practice in OSA. If the outcomes are good these stategies could be applied to reduce the waiting times for to diagnose and manage OSA and make therapy more widely available throughout the community.Read moreRead less
Recognition And Management Of Sleep Apnea In Primary Care
Funder
National Health and Medical Research Council
Funding Amount
$650,866.00
Summary
Obstructive sleep apnoea (OSA, ie frequent choking episodes during sleep, associated oxygen deprivation and sleep disturbance) affects at least 4% of the adult population and leads to serious health problems if untreated. These health problems include excessive tiredness, fall-asleep accidents, and premature stroke and heart attacks. Currently patients suspected of OSA are referred for management to specialist sleep centres, where sleep specialists order overnight laboratory tests to confirm the ....Obstructive sleep apnoea (OSA, ie frequent choking episodes during sleep, associated oxygen deprivation and sleep disturbance) affects at least 4% of the adult population and leads to serious health problems if untreated. These health problems include excessive tiredness, fall-asleep accidents, and premature stroke and heart attacks. Currently patients suspected of OSA are referred for management to specialist sleep centres, where sleep specialists order overnight laboratory tests to confirm the diagnosis and test the effects of treatment (CPAP via a nasal mask) and thereafter direct management. These centres are not coping with current demand because of too few specialists and too few testing facilities. But worse than this up to 85% of cases in the community are not being identified. Many patients with OSA attend general practitioners for sometimes related conditions such as hypertension, diabetes and obesity, but are unrecognised for having a serious sleep disorder. This study will develop new and simplified methods of home diagnosis of OSA suitable for general practice. It will then use these methods to identify patients in general practice with moderate to severe OSA who will then enter a study that compares the effectiveness and the cost effectiveness of two models of care where the principle treatment will be CPAP: One is a new model which will be based in patients homes and general practice surgeries, the other, will be current standard care in our specialist sleep centre. We postulate that general practice based care will be as effective for patients as specialist sleep centre care but will be less costly. If this proves to be the case the study results will open the possibility for easier access to care for a larger number of patients with moderate to severe OSA, which will result in significant health benefits for the community.Read moreRead less